Lower Limb Arterial Ischemia: An Independent Risk Factor of Sudomotor Dysfunction in Type 2 Diabetes

References

• Pop-Busui R, Boulton A, Feldman EL, et al. Diabetic neuropathy: a position statement by the American diabetes association. Diabetes Care. 2017;40(1):136–154.
   PubMed Web of Science ®Google Scholar
• Hicks CW, Selvin E. Epidemiology of peripheral neuropathy and lower extremity disease in diabetes. Curr Diab Rep. 2019;19(10):86.
   PubMed Web of Science ®Google Scholar
• Vinik AI, Nevoret ML, Casellini C. The New Age of Sudomotor Function Testing: a Sensitive and Specific Biomarker for Diagnosis, Estimation of Severity, Monitoring Progression, and Regression in Response to Intervention. Front Endocrinol (Lausanne). 2015;6:94.
   PubMed Web of Science ®Google Scholar
• Tentolouris N, Marinou K, Kokotis P, Karanti A, Diakoumopoulou E, Katsilambros N. Sudomotor dysfunction is associated with foot ulceration in diabetes. Diabet Med. 2009;26(3):302–305.
   PubMed Web of Science ®Google Scholar
• Panagoulias GS, Eleftheriadou I, Papanas N, et al. Dryness of foot skin assessed by the visual indicator test and risk of diabetic foot ulceration: a prospective observational study. Front Endocrinol (Lausanne). 2020;11:625.
   PubMed Web of Science ®Google Scholar
• Weber F, Ziegler A. Axonal neuropathy in chronic peripheral arterial occlusive disease. Muscle Nerve. 2002;26(4):471–476.
   PubMed Web of Science ®Google Scholar
• Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A, Group KS. Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care. 2008;31(3):464–469.
   PubMed Web of Science ®Google Scholar
• Argyriou AA, Tsolakis I, Papadoulas S, Polychronopoulos P, Gourzis P, Chroni E. Sympathetic skin response in patients with peripheral arterial occlusive disease. Clin Neurophysiol. 2006;117(2):414–419.
   PubMed Web of Science ®Google Scholar
• Chahal S, Vohra K, Syngle A. Association of sudomotor function with peripheral artery disease in type 2 diabetes. Neurol Sci. 2017;38(1):151–156.
   PubMed Web of Science ®Google Scholar
• Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary. Vasc Med. 2017;22(3):Np1–Np43.
   PubMed Web of Science ®Google Scholar
• Meloni M, Izzo V, Giurato L, Gandini R, Uccioli L. Below-The-ankle arterial disease severely impairs the outcomes of diabetic patients with ischemic foot ulcers. Diabetes Res Clin Pract. 2019;152:9–15.
   PubMed Web of Science ®Google Scholar
• Hoyer C, Sandermann J, Petersen LJ. The toe-brachial index in the diagnosis of peripheral arterial disease. J Vasc Surg. 2013;58(1):231–238.
   PubMed Web of Science ®Google Scholar
• Manu CA, Freedman B, Rashid H, Winkley K, Edmonds ME. Peripheral Arterial Disease Located in the Feet of Patients With Diabetes and Foot Ulceration Demands a New Approach to the Assessment of Ischemia. Int J Low Extrem Wounds. 2020;2:1534734620947979.
   Google Scholar
• Biro K, Sandor B, Kovacs D, et al. Lower limb ischemia and microrheological alterations in patients with diabetic retinopathy. Clin Hemorheol Microcirc. 2018;69(1–2):23–35.
   PubMed Web of Science ®Google Scholar
• Zografou I, Iliadis F, Sambanis C, Didangelos T. Validation of Neuropad in the Assessment of Peripheral Diabetic Neuropathy in Patients with Diabetes Mellitus Versus the Michigan Neuropathy Screening Instrument, 10g Monofilament Application and Biothesiometer Measurement. Curr Vasc Pharmacol. 2020;18(5):517–522.
   PubMed Web of Science ®Google Scholar
• Curry SJ, Krist AH, Owens DK, et al. Screening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment With the Ankle-Brachial Index US Preventive Services Task Force Recommendation Statement. JAMA-J Am Med Assoc. 2018;320(2):177–183.
   PubMed Web of Science ®Google Scholar
• Hinchliffe RJ, Forsythe RO, Apelqvist J, et al. Guidelines of the international writing group on the diabetic foot on diagnosis. Diabetes-Metab Res. 2020;36.
   Web of Science ®Google Scholar
• Fife CE, Smart DR, Sheffield PJ, Hopf HW, Hawkins G, Clarke D. Transcutaneous oximetry in clinical practice: consensus statements from an expert panel based on evidence. Undersea Hyperb Med. 2009;36(1):43–53.
   PubMed Web of Science ®Google Scholar
• Ponirakis G, Petropoulos IN, Fadavi H, et al. The diagnostic accuracy of Neuropad (R) for assessing large and small fibre diabetic neuropathy. Diabetic Med. 2014;31(12):1673–1680.
   PubMed Web of Science ®Google Scholar
• Ziegler D, Papanas N, Zhivov A, et al. Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes. Diabetes. 2014;63(7):2454–2463.
   PubMed Web of Science ®Google Scholar
• Lanzer P, Boehm M, Sorribas V, et al. Medial vascular calcification revisited: review and perspectives. Eur Heart J. 2014;35(23):1515–1525.
   PubMed Web of Science ®Google Scholar
• Ix JH, Miller RG, Criqui MH, Orchard TJ. Test characteristics of the ankle-brachial index and ankle-brachial difference for medial arterial calcification on X-ray in type 1 diabetes. J Vasc Surg. 2012;56(3):721–727.
   PubMed Web of Science ®Google Scholar
• Jeffcoate WJ, Rasmussen LM, Hofbauer LC, Game FL. Medial arterial calcification in diabetes and its relationship to neuropathy. Diabetologia. 2009;52(12):2478–2488.
   PubMed Web of Science ®Google Scholar
• Ferraresi R, Mauri G, Losurdo F, et al. BAD transmission and SAD distribution: a new scenario for critical limb ischemia. J Cardiovasc Surg (Torino). 2018;59(5):655–664.
   PubMed Web of Science ®Google Scholar
• Williams DT, Harding KG, Price P. An evaluation of the efficacy of methods used in screening for lower-limb arterial disease in diabetes. Diabetes Care. 2005;28(9):2206–2210.
   PubMed Web of Science ®Google Scholar
• Faglia E, Clerici G, Caminiti M, Quarantiello A, Curci V, Somalvico F. Evaluation of feasibility of ankle pressure and foot oximetry values for the detection of critical limb ischemia in diabetic patients. Vasc Endovascular Surg. 2010;44(3):184–189.
   PubMed Web of Science ®Google Scholar
• Rossi M, Carpi A. Skin microcirculation in peripheral arterial obliterative disease. Biomed Pharmacother. 2004;58(8):427–431.
   PubMed Web of Science ®Google Scholar
• Catella J, Long A, Mazzolai L. What Is Currently the Role of TcPO2 in the Choice of the Amputation Level of Lower Limbs? A Comprehensive Review. J Clin Med. 2021;10(7):89.
   Web of Science ®Google Scholar
• Lee JB, Kim JH, Murota H. Perspiration Functions in Different Ethnic, Age, and Sex Populations: modification of Sudomotor Function. Curr Probl Dermatol. 2016;51:109–119.
   PubMedGoogle Scholar
• Feng ZQ, Guo QY, Wang W, et al. Time in range, especially overnight time in range, is associated with sudomotor dysfunction in patients with type 1 diabetes. Diabetol Metab Syndr. 2021;13(1):119.
   PubMed Web of Science ®Google Scholar
• Shivaprasad C, Amit G, Anish K, Rakesh B, Anupam B, Aiswarya Y. Clinical correlates of sudomotor dysfunction in patients with type 2 diabetes and peripheral neuropathy. Diabetes Res Clin Pract. 2018;139:188–194.
   PubMed Web of Science ®Google Scholar
• de Camargo CRS, Schoueri JHM, Alves BDA, da Veiga GRL, Fonseca FLA, Bocci MR. Uremic neuropathy: an overview of the current literature. Rev Assoc Med Bras. 2019;65(3):469–474.
   PubMed Web of Science ®Google Scholar